Browsing by Author "Soler, Monica"

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Gold Nanoparticles Mediate Improved Detection of β-amyloid Aggregates by Fluorescence
    (2020) Jara-Guajardo, Pedro; Cabrera, Pablo; Celis, Freddy; Soler, Monica; Berlanga, Isadora; Parra-Munoz, Nicole; Acosta, Gerardo; Albericio, Fernando; Guzman, Fanny; Campos, Marcelo; Alvarez, Alejandra; Morales-Zavala, Francisco; Kogan, Marcelo J.
    The early detection of the amyloid beta peptide aggregates involved in Alzheimer's disease is crucial to test new potential treatments. In this research, we improved the detection of amyloid beta peptide aggregates in vitro and ex vivo by fluorescence combining the use of CRANAD-2 and gold nanorods (GNRs) by the surface enhancement fluorescence effect. We synthetized GNRs and modified their surface with HS-PEG-OMe and HS-PEG-COOH and functionalized them with the D1 peptide, which has the capability to selectively bind to amyloid beta peptide. For an in vitro detection of amyloid beta peptide, we co-incubated amyloid beta peptide aggregates with the probe CRANAD-2 and GNR-PEG-D1 observing an increase in the intensity of the fluorescence signal attributed to surface enhancement fluorescence. Furthermore, the surface enhancement fluorescence effect was observed in brain slices of transgenic mice with Alzheimer's disease co-incubated with CRANAD-2 and GNR-PEG-D1. An increase in the fluorescence signal was observed allowing the detection of aggregates that cannot be detected with the single use of CRANAD-2. Gold nanoparticles allowed an improvement in the detection of the amyloid aggregated by fluorescence in vitro and ex vivo.
  • No Thumbnail Available
    Item
    Surface enhanced fluorescence effect improves the in vivo detection of amyloid aggregates
    (2022) Cabrera, Pablo; Jara-Guajardo, Pedro; Oyarzun, Maria Paz; Parra-Munoz, Nicole; Campos, Aldo; Soler, Monica; Alvarez, Alejandra; Morales-Zavala, Francisco; Araya, Eyleen; Minniti, Alicia N.; Aldunate, Rebeca; Kogan, Marcelo J.
    The beta-amyloid (A beta) peptide is one of the key etiological agents in Alzheimer's disease (AD). The in vivo detection of A beta species is challenging in all stages of the illness. Currently, the development of fluorescent probes allows the detection of A beta in animal models in the near-infrared region (NIR). However, considering future applications in biomedicine, it is relevant to develop strategies to improve detection of amyloid aggregates using NIR probes. An innovative approach to increase the fluorescence signal of these fluorophores is the use of plasmonic gold nanoparticles (surface-enhanced fluorescence effect). In this work, we improved the detection of A beta aggregates in C. elegans and mouse models of AD by co-administering functionalized gold nanorods (GNRs-PEG-D1) with the fluorescent probes CRANAD-2 or CRANAD-58, which bind selectively to different amyloid species (soluble and insoluble). This work shows that GNRs improve the detection of A beta using NIR probes in vivo. (C) 2022 Published by Elsevier Inc.